The Influence of Magnesium Sulphate Pretreatment on Intubating Conditions During Rapid Sequence Induction
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 168
- 试验地点
- 1
- 主要终点
- the intubating conditions
研究概览
简要总结
Magnesium had an inhibitory effect on neuromuscular transmission and caused a decrease in muscle fiber membrane excitability. It reduces the amount of acetylcholine that is released at the motor nerve terminal by decreasing the calcium conductance of presynaptic voltage-dependent calcium channels. After pre-treatment with magnesium, an increased speed of onset and a prolongation of the recovery period of neuromuscular blockade have been observed with other non-depolarizing neuromuscular blocking agent (NMBA) such as atracurium, vecuronium and rocuronium. Rocuronium is the currently preferred NMBA used as an alternative to succinylcholine for rapid tracheal intubation. As an alternative to succinylcholine, high doses of NMBA have been tested for rapid sequence intubation. This excessively high dose of rocuronium, however, prolongs the duration of the neuromuscular block and this may not be warranted in every surgical setting.
The reduction of onset time of rocuronium by magnesium pre-treatment can make intubation condition more rapid and much better clinically. It will thus be interesting to compare intubation conditions of a standard intubation dose of rocuronium after magnesium pre-treatment with high dose of rocuronium or standard dose of rocuronium.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 20 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •patients undergoing operation under general anesthesia
- •American Society of Anesthesiologist physical status I or II
- •20-65 year old male or female
排除标准
- •hepatic or renal dysfunction
- •respiratory or cardiovascular dysfunction
- •neurologic disorder
- •neuromuscular disease
- •pregnancy
- •body mass index (BMI) >30 kg/m2 or <16.5 kg/m2
- •anticipated difficult airway
- •higher magnesium level than normal range in preoperative evaluation
- •chronic medication with calcium channel blocker or magnesium
- •history of known allergy to magnesium sulphate or any other study drugs
研究组 & 干预措施
group M
干预措施: magnesium sulphate (Drug)
Group R-0.6
干预措施: normal saline (Drug)
Group R-0.9
干预措施: normal saline (Drug)
结局指标
主要结局
the intubating conditions
时间窗: 1 minute during intervention
The anesthesiologist also assessed the intubating conditions as per the intubation scoring system of the Good Clinical Research Practice guideline.
次要结局
- mean arterial pressure (MAP)(5 min before intubation, immediate before intubation, post-intubation 1, 2, 3, 4, and 5 min.)
- heart rate (HR)(5 min before intubation, immediate before intubation, post-intubation 1, 2, 3, 4, and 5 min.)
研究者
Hyo-Seok Na
professor
Seoul National University Bundang Hospital
